WTC
CORT icon

WhitTier Trust Company’s Corcept Therapeutics CORT Stock Holding History

WhitTier Trust Company’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-329
Closed -$29K – 1279
2025
Q3 		$29K Buy
329
+121
+58% +$8.76K ﹤0.01% 806
2025
Q2 		$15.3K Buy
+208
New +$15.1K ﹤0.01% 1063

Other funds holding CORT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

WhitTier Trust Company's CORT Position: Q4 2025 in Review

WhitTier Trust Company sold out of Corcept Therapeutics (CORT) in Q4 2025, closing a stake of 329 shares — an estimated $29K sold.

WhitTier Trust Company first reported a position in CORT in Q2 2025 and held it in 2 quarters. The position peaked at $29K in Q3 2025. 389 funds tracked by Wall St. Rank hold CORT as of Q4 2025.

  • WhitTier Trust Company reported no remaining Corcept Therapeutics position as of Q4 2025 after selling out during the quarter.
  • WhitTier Trust Company sold 329 Corcept Therapeutics shares in Q4 2025, an estimated $29K.
  • WhitTier Trust Company first reported a position in Corcept Therapeutics in Q2 2025 and held it in 2 quarters.
  • WhitTier Trust Company's Corcept Therapeutics position peaked at $29K in Q3 2025.
  • 389 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q4 2025.

Based on WhitTier Trust Company's 13F filing for Q4 2025, filed 26 Jan 2026.